Drugs / BPR277
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01428297 | May 2011 → Feb 2014 | Netherton syndrome, atopic eczema | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BPR277 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01428297 ↗ |
| Route | Topical | “Topical BPR277” NCT01428297 ↗ |